Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 374

1.

Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society.

Toyoda K, Koga M, Iguchi Y, Itabashi R, Inoue M, Okada Y, Ogasawara K, Tsujino A, Hasegawa Y, Hatano T, Yamagami H, Iwama T, Shiokawa Y, Terayama Y, Minematsu K.

Neurol Med Chir (Tokyo). 2019 Dec 5. doi: 10.2176/nmc.st.2019-0177. [Epub ahead of print] No abstract available.

2.
3.

Risk factors for infarct expansion are different between lacunar and giant lacunar infarction.

Sato T, Sakai K, Komatsu T, Sakuta K, Terasawa Y, Omoto S, Mitsumura H, Iguchi Y.

Atherosclerosis. 2019 Nov 1;292:17-22. doi: 10.1016/j.atherosclerosis.2019.10.018. [Epub ahead of print]

PMID:
31731081
4.

Multicenter Prospective Analysis of Stroke Patients Taking Oral Anticoagulants: The PASTA Registry - Study Design and Characteristics.

Suda S, Iguchi Y, Fujimoto S, Yagita Y, Kono Y, Ueda M, Todo K, Kono T, Mizunari T, Yamazaki M, Kanzawa T, Okubo S, Kondo K, Nakajima N, Inoue T, Iwanaga T, Nakajima M, Imafuku I, Shibazaki K, Mishina M, Adachi K, Nomura K, Nakajima M, Yaguchi H, Okamoto S, Osaki M, Terasawa Y, Nagao T, Kimura K.

J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104456. doi: 10.1016/j.jstrokecerebrovasdis.2019.104456. Epub 2019 Oct 29.

PMID:
31676161
5.

Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis.

Ito D, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Iida M, Kishimoto Y, Moriyoshi H, Hirakawa A, Katsuno M.

J Neurol. 2019 Dec;266(12):2952-2961. doi: 10.1007/s00415-019-09507-6. Epub 2019 Aug 27.

PMID:
31456060
6.

TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets.

Araki K, Araki A, Honda D, Izumoto T, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Hara A, Ikumi K, Kawai K, Ishigaki S, Nakamichi Y, Tsunekawa S, Seino Y, Yamamoto A, Takayama Y, Hidaka S, Tominaga M, Ohara-Imaizumi M, Suzuki A, Ishiguro H, Enomoto A, Yoshida M, Arima H, Muramatsu SI, Sobue G, Katsuno M.

J Clin Invest. 2019 Jul 29;130:3578-3593. doi: 10.1172/JCI124481. eCollection 2019 Jul 29.

7.

Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.

Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS Investigators.

J Am Heart Assoc. 2019 Aug 6;8(15):e012652. doi: 10.1161/JAHA.119.012652. Epub 2019 Jul 26.

8.

[Diagnosis and Treatment of Cognitive Impairment in Parkinson's Disease].

Shiraishi T, Murakami H, Iguchi Y.

Brain Nerve. 2019 Aug;71(8):869-874. doi: 10.11477/mf.1416201367. Review. Japanese.

PMID:
31346143
9.

Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study.

Sakamoto Y, Nishiyama Y, Iwasaki YK, Daida H, Toyoda K, Kitagawa K, Okumura K, Kusano K, Hagiwara N, Fujimoto S, Miyamoto S, Otsuka T, Iguchi Y, Kanamaru T, Yamamoto T, Kaburagi J, Kimura T, Matsumoto T, Kimura K, Shimizu W; STABLED Study Investigators.

J Cardiol. 2019 Dec;74(6):539-542. doi: 10.1016/j.jjcc.2019.06.002. Epub 2019 Jul 20.

10.

Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: Comprehensive understanding of structure-activity relationship of FXR antagonists.

Teno N, Yamashita Y, Masuda A, Iguchi Y, Oda K, Fujimori K, Hiramoto T, Nishimaki-Mogami T, Une M, Gohda K.

Bioorg Med Chem. 2019 Jun 1;27(11):2220-2227. doi: 10.1016/j.bmc.2019.04.029. Epub 2019 Apr 20.

PMID:
31029550
11.

Microbleeds of Lacunar Infarction and Middle Cerebral Artery Flow Velocity of Branch Atheromatous Disease Are Essential Factors of Stroke Etiology.

Terasawa Y, Sakai K, Komatsu T, Sakuta K, Omoto S, Mitsumura H, Iguchi Y.

Eur Neurol. 2019;81(1-2):19-23. doi: 10.1159/000494672. Epub 2019 Apr 23.

PMID:
31013495
12.

Female genital cutting in Malaysia: a mixed-methods study.

Rashid A, Iguchi Y.

BMJ Open. 2019 Apr 1;9(4):e025078. doi: 10.1136/bmjopen-2018-025078.

13.

The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study).

Suzuki K, Kimura K, Takeuchi M, Morimoto M, Kanazawa R, Kamiya Y, Shigeta K, Ishii N, Takayama Y, Koguchi Y, Takigawa T, Hayakawa M, Ota T, Okubo S, Naito H, Akaji K, Kato N, Inoue M, Hirano T, Miki K, Ueda T, Iguchi Y, Fujimoto S, Otsuka T, Matsumaru Y.

Int J Stroke. 2019 Oct;14(7):752-755. doi: 10.1177/1747493019840932. Epub 2019 Mar 29.

PMID:
30924762
14.
15.

Renal perfusion, oxygenation, and sympathetic nerve activity during volatile or intravenous general anaesthesia in sheep.

Iguchi N, Kosaka J, Booth LC, Iguchi Y, Evans RG, Bellomo R, May CN, Lankadeva YR.

Br J Anaesth. 2019 Mar;122(3):342-349. doi: 10.1016/j.bja.2018.11.018. Epub 2019 Jan 11.

PMID:
30770052
16.

Large but Nonstenotic Carotid Artery Plaque in Patients With a History of Embolic Stroke of Undetermined Source.

Komatsu T, Iguchi Y, Arai A, Sakuta K, Sakai K, Terasawa Y, Mitsumura H, Matsushima M.

Stroke. 2018 Dec;49(12):3054-3056. doi: 10.1161/STROKEAHA.118.022986.

PMID:
30571401
17.

The NAG Scale: Noble Predictive Scale for Hematoma Expansion in Intracerebral Hemorrhage.

Sakuta K, Komatsu T, Sakai K, Terasawa Y, Mitsumura H, Iguchi Y.

J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3675. doi: 10.1016/j.jstrokecerebrovasdis.2018.09.031. Epub 2018 Oct 24. No abstract available.

PMID:
30473027
18.

Transcranial color-coded sonography findings of patients with reversible cerebral vasoconstriction syndromes.

Terasawa Y, Arai A, Sakai K, Mitsumura H, Iguchi Y.

J Clin Neurosci. 2019 Mar;61:290-292. doi: 10.1016/j.jocn.2018.11.002. Epub 2018 Nov 22.

PMID:
30470655
19.

Nerve Ultrasound, Electrophysiological, and Clinical Changes in Treatment-Naive Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report.

Sato T, Terasawa Y, Higa H, Matsuno H, Arai A, Omoto S, Mitsumura H, Toyoda C, Koike H, Iguchi Y.

J Clin Neurophysiol. 2019 Jan;36(1):82-84. doi: 10.1097/WNP.0000000000000524.

PMID:
30260816
20.

Preclinical progression of neurodegenerative diseases.

Katsuno M, Sahashi K, Iguchi Y, Hashizume A.

Nagoya J Med Sci. 2018 Aug;80(3):289-298. doi: 10.18999/nagjms.80.3.289. Review.

21.

A novel probe attached to the neck can accurately detect a large patent foramen ovale.

Mitsumura H, Arai A, Sato T, Komatsu T, Sakuta K, Sakai K, Terasawa Y, Kubota J, Iguchi Y.

J Neurol Sci. 2018 Sep 15;392:122-125. doi: 10.1016/j.jns.2018.07.014. Epub 2018 Jul 20.

PMID:
30055383
22.

Heterozygous HTRA1 mutations with mimicking symptoms of CARASIL in two families.

Kono Y, Nishioka K, Li Y, Komatuzaki Y, Ito Y, Yoshino H, Tanaka R, Iguchi Y, Hattori N.

Clin Neurol Neurosurg. 2018 Sep;172:174-176. doi: 10.1016/j.clineuro.2018.07.009. Epub 2018 Jul 19.

PMID:
30031255
23.

The NAG scale: Noble Predictive Scale for Hematoma Expansion in Intracerebral Hemorrhage.

Sakuta K, Sato T, Komatsu T, Sakai K, Terasawa Y, Mitsumura H, Iguchi Y.

J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2606-2612. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.020. Epub 2018 Jun 27.

PMID:
29958849
24.

Acute ischemic stroke as a complication of Stanford type A acute aortic dissection: a review and proposed clinical recommendations for urgent diagnosis.

Koga M, Iguchi Y, Ohara T, Tahara Y, Fukuda T, Noguchi T, Matsuda H, Minatoya K, Nagatsuka K, Toyoda K.

Gen Thorac Cardiovasc Surg. 2018 Aug;66(8):439-445. doi: 10.1007/s11748-018-0956-4. Epub 2018 Jun 13. Review.

PMID:
29948797
25.

Real-time multiplex PCR for simultaneous detection of multiple species from environmental DNA: an application on two Japanese medaka species.

Tsuji S, Iguchi Y, Shibata N, Teramura I, Kitagawa T, Yamanaka H.

Sci Rep. 2018 Jun 14;8(1):9138. doi: 10.1038/s41598-018-27434-w.

26.

Single-Crystal Growth of Cl-Doped n-Type SnS Using SnCl2 Self-Flux.

Iguchi Y, Inoue K, Sugiyama T, Yanagi H.

Inorg Chem. 2018 Jun 18;57(12):6769-6772. doi: 10.1021/acs.inorgchem.8b00646. Epub 2018 Jun 5.

PMID:
29869875
27.

Urgent Detection of Acute Type A Aortic Dissection in Hyperacute Ischemic Stroke or Transient Ischemic Attack.

Tokuda N, Koga M, Ohara T, Minatoya K, Tahara Y, Higashi M, Miyazaki Y, Kajimoto K, Matsubara S, Makita N, Sakamoto Y, Iguchi Y, Mizuno T, Nagatsuka K, Toyoda K.

J Stroke Cerebrovasc Dis. 2018 Aug;27(8):2112-2117. doi: 10.1016/j.jstrokecerebrovasdis.2018.03.010. Epub 2018 Apr 10.

PMID:
29653804
28.

Neuronal intranuclear hyaline inclusion disease presenting with childhood-onset night blindness associated with progressive retinal dystrophy.

Omoto S, Hayashi T, Matsuno H, Higa H, Kameya S, Sengoku R, Takahashi-Fujigasaki J, Murayama S, Iguchi Y.

J Neurol Sci. 2018 May 15;388:84-86. doi: 10.1016/j.jns.2018.03.010. Epub 2018 Mar 6. No abstract available.

PMID:
29627037
29.

Cerebrovascular imaging of cerebral ischemia in acute type A aortic dissection.

Matsubara S, Koga M, Ohara T, Iguchi Y, Minatoya K, Tahara Y, Fukuda T, Miyazaki Y, Kajimoto K, Sakamoto Y, Makita N, Tokuda N, Nagatsuka K, Ando Y, Toyoda K.

J Neurol Sci. 2018 May 15;388:23-27. doi: 10.1016/j.jns.2018.02.044. Epub 2018 Feb 27.

PMID:
29627025
30.

Nonacidic Chemotype Possessing N-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) Antagonists.

Teno N, Yamashita Y, Iguchi Y, Fujimori K, Une M, Nishimaki-Mogami T, Hiramoto T, Gohda K.

ACS Med Chem Lett. 2018 Jan 4;9(2):78-83. doi: 10.1021/acsmedchemlett.7b00363. eCollection 2018 Feb 8.

31.

Ethological and multi-behavioral analysis of learning and memory performance in laboratory rodent models.

Arakawa H, Iguchi Y.

Neurosci Res. 2018 Oct;135:1-12. doi: 10.1016/j.neures.2018.02.001. Epub 2018 Feb 9. Review.

PMID:
29432797
32.

Preferential atrophy of the central retinal ganglion cells in homonymous hemianopia due to acquired retrogeniculate lesions demonstrated using swept-source optical coherence tomography.

Yamashita T, Miki A, Goto K, Araki S, Takizawa G, Ieki Y, Kiryu J, Tabuchi A, Iguchi Y, Kimura K, Yagita Y.

Acta Ophthalmol. 2018 Jun;96(4):e538-e539. doi: 10.1111/aos.13644. Epub 2017 Nov 30. No abstract available.

33.

Thrombotic Microangiopathy Presenting with Intestinal Involvement Following Long-term Interferon-β1b Treatment for Multiple Sclerosis.

Omoto S, Utsumi T, Matsuno H, Terasawa Y, Iguchi Y.

Intern Med. 2018 Mar 1;57(5):741-744. doi: 10.2169/internalmedicine.9326-17. Epub 2017 Nov 20.

34.

Yield of combined MRI sequences in isolated cortical vein thrombosis diagnosis.

Sato T, Sakuta K, Komatsu T, Sakai K, Terasawa Y, Mitsumura H, Iguchi Y.

J Neurol Sci. 2017 Oct 15;381:328-330. doi: 10.1016/j.jns.2017.09.008. Epub 2017 Sep 8. No abstract available.

PMID:
28991710
35.

Molecular and morphological analyses revealed a cryptic species of dojo loach Misgurnus anguillicaudatus (Cypriniformes: Cobitidae) in Japan.

Okada R, Inui T, Iguchi Y, Kitagawa T, Takata K, Kitagawa T.

J Fish Biol. 2017 Sep;91(3):989-996. doi: 10.1111/jfb.13393.

PMID:
28868749
36.

Continuous flow reduced-pressure infrared laser desorption/ionization mass spectrometry.

Iguchi Y, Hazama H, Awazu K.

Rapid Commun Mass Spectrom. 2017 Nov 15;31(21):1845-1850. doi: 10.1002/rcm.7970.

PMID:
28850755
37.

Venous Stasis and Cerebrovascular Complications in Cerebral Venous Sinus Thrombosis.

Sato T, Terasawa Y, Mitsumura H, Komatsu T, Sakuta K, Sakai K, Matsushima S, Iguchi Y.

Eur Neurol. 2017;78(3-4):154-160. doi: 10.1159/000478980. Epub 2017 Aug 23.

PMID:
28848116
38.

Magnetoelectrical control of nonreciprocal microwave response in a multiferroic helimagnet.

Iguchi Y, Nii Y, Onose Y.

Nat Commun. 2017 May 8;8:15252. doi: 10.1038/ncomms15252.

39.

Transcranial color-coded sonography of vertebral artery for diagnosis of right-to-left shunts.

Komatsu T, Terasawa Y, Arai A, Sakuta K, Mitsumura H, Iguchi Y.

J Neurol Sci. 2017 May 15;376:97-101. doi: 10.1016/j.jns.2017.03.012. Epub 2017 Mar 10.

PMID:
28431637
40.

Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist.

Fujita K, Iguchi Y, Une M, Watanabe S.

Lipids. 2017 Apr;52(4):335-344. doi: 10.1007/s11745-017-4242-5. Epub 2017 Mar 17.

PMID:
28315136
41.

Chronic kidney disease is independently associated with acute recurrent cerebral infarct in patients with atrial fibrillation.

Sakuta K, Iguchi Y, Sato T, Sakai K, Terasawa Y, Mitsumura H.

J Clin Neurosci. 2017 Jun;40:97-101. doi: 10.1016/j.jocn.2017.02.013. Epub 2017 Mar 9.

PMID:
28284577
42.

An uncovered risk factor of sonothrombolysis: Substantial fluctuation of ultrasound transmittance through the human skull.

Wang Z, Komatsu T, Mitsumura H, Nakata N, Ogawa T, Iguchi Y, Yokoyama M.

Ultrasonics. 2017 May;77:168-175. doi: 10.1016/j.ultras.2017.02.012. Epub 2017 Feb 16.

PMID:
28242510
43.
44.

Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists.

Teno N, Iguchi Y, Yamashita Y, Mori N, Une M, Nishimaki-Mogami T, Gohda K.

Bioorg Med Chem. 2017 Mar 15;25(6):1787-1794. doi: 10.1016/j.bmc.2017.01.040. Epub 2017 Jan 31.

PMID:
28190654
45.

An In Vitro Assay for Sonothrombolysis Based on the Spectrophotometric Measurement of Clot Thickness.

Wang Z, Sawaguchi Y, Hirose H, Ohara K, Sakamoto S, Mitsumura H, Ogawa T, Iguchi Y, Yokoyama M.

J Ultrasound Med. 2017 Apr;36(4):681-698. doi: 10.7863/ultra.15.11018. Epub 2017 Feb 2.

PMID:
28150461
46.

Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.

Ishigaki S, Fujioka Y, Okada Y, Riku Y, Udagawa T, Honda D, Yokoi S, Endo K, Ikenaka K, Takagi S, Iguchi Y, Sahara N, Takashima A, Okano H, Yoshida M, Warita H, Aoki M, Watanabe H, Okado H, Katsuno M, Sobue G.

Cell Rep. 2017 Jan 31;18(5):1118-1131. doi: 10.1016/j.celrep.2017.01.013.

47.

YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy).

Aoki J, Kimura K, Morita N, Harada M, Metoki N, Tateishi Y, Todo K, Yamagami H, Hayashi K, Terasawa Y, Fujita K, Yamamoto N, Deguchi I, Tanahashi N, Inoue T, Iwanaga T, Kaneko N, Mitsumura H, Iguchi Y, Ueno Y, Kuramoto Y, Ogata T, Fujimoto S, Yokoyama M, Nagahiro S; YAMATO Study Investigators.

Stroke. 2017 Mar;48(3):712-719. doi: 10.1161/STROKEAHA.116.015042. Epub 2017 Jan 24.

PMID:
28119434
48.

Coccygeal Pad With an Anterior Flexed Coccyx: A Case Report.

Hikiami R, Kakudo N, Iguchi Y, Katsube M, Morimoto N, Hihara M, Mitsui T, Yamauchi T, Kusumoto K.

Eplasty. 2016 Aug 31;16:e25. eCollection 2016.

49.

Exosome secretion is a key pathway for clearance of pathological TDP-43.

Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, Kawai K, Takagi S, Yoshida M, Katsuno M, Sobue G, Julien JP.

Brain. 2016 Dec;139(Pt 12):3187-3201. Epub 2016 Sep 27.

50.

Gene Expression Profile of Inflammatory Myopathy with Malignancy is Similar to that of Dermatomyositis rather than Polymyositis.

Noda T, Iijima M, Noda S, Maeshima S, Nakanishi H, Kimura S, Koike H, Ishigaki S, Iguchi Y, Katsuno M, Sobue G.

Intern Med. 2016;55(18):2571-80. doi: 10.2169/internalmedicine.55.6706. Epub 2016 Sep 15.

Supplemental Content

Loading ...
Support Center